Erasca, Inc.
Headquarters country
United States
Registry sponsor category
Industry
- Other names
- Erasca, Inc.
- Company name
- Erasca, Inc.
- Organisation type
- Industry
- Registered legal name
- Erasca, Inc.
- US industry code (SIC)
- Pharmaceutical preparations
- Registry sponsor category
- Industry
- SEC filer number (CIK)
- 0001761918
Related records
Trials (10)
- A Dose Escalation/Expansion Study of ERAS-601 in Patients With Advanced or Metastatic Solid Tumors
- A Study of Anti-Cancer Therapies Targeting the MAPK Pathway in Patients With Advanced NSCLC
- A Study of Anti-Cancer Therapies Targeting the MAPK Pathway in Patients With Hematologic Malignancies
- A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
- A Study of ERAS-007 as Monotherapy or in Combination With ERAS-601 in Patients With Advanced or Metastatic Solid Tumors
- A Study of ERAS-007 in Patients With Advanced Gastrointestinal Malignancies
- A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors.
- A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2)
- A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With RAS Q61X Mutations
- A Study to Evaluate ERAS-801 in Patients With Recurrent Glioblastoma (THUNDERBBOLT-1)